Cargando…
Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune–Albright Syndrome
Fibrous dysplasia (FD) is a rare, non-inherited bone disease occurring following a somatic gain-of-function R201 missense mutation of the guanine-nucleotide binding protein alpha subunit stimulating activity polypeptide 1 (GNAS) gene. The spectrum of the disease ranges from a single FD lesion to a c...
Autores principales: | Tucker-Bartley, Anthony, Selen, Daryl J., Golden, Emma, van Gool, Raquel, Ebb, David, Mannstadt, Michael, Upadhyay, Jaymin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916440/ https://www.ncbi.nlm.nih.gov/pubmed/36768871 http://dx.doi.org/10.3390/ijms24032550 |
Ejemplares similares
-
McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia
por: Collins, Michael T, et al.
Publicado: (2012) -
Advances in Models of Fibrous Dysplasia/McCune-Albright Syndrome
por: Lung, Hsuan, et al.
Publicado: (2020) -
Gynecologic and reproductive outcomes in fibrous dysplasia/McCune-Albright syndrome
por: Boyce, Alison M., et al.
Publicado: (2019) -
Neuropathic-like Pain in Fibrous Dysplasia/McCune-Albright Syndrome
por: Spencer, Tiahna L, et al.
Publicado: (2022) -
McCune-Albright syndrome
por: Dumitrescu, Claudia E, et al.
Publicado: (2008)